Intelligent Bio Solutions Stock One Year Return
| INBS Stock | USD 1.47 0.01 0.68% |
Fundamental analysis of Intelligent Bio allows traders to better anticipate movements in Intelligent Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.
Intelligent | One Year Return | Build AI portfolio with Intelligent Stock |
Intelligent Bio Solutions Company One Year Return Analysis
Intelligent Bio's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Intelligent One Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Intelligent Bio is extremely important. It helps to project a fair market value of Intelligent Stock properly, considering its historical fundamentals such as One Year Return. Since Intelligent Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intelligent Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intelligent Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Intelligent Return On Tangible Assets
Return On Tangible Assets |
|
Based on the recorded statements, Intelligent Bio Solutions has an One Year Return of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Intelligent One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.Intelligent Bio is currently under evaluation in one year return category among its peers.
Intelligent Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intelligent Bio from analyzing Intelligent Bio's financial statements. These drivers represent accounts that assess Intelligent Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intelligent Bio's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 53.5M | 9.7M | 475.4K | 787.9K | 2.5M | 2.4M | |
| Enterprise Value | 40.9M | 1.5M | 273.8K | (4.6M) | 1.8M | 1.7M |
Intelligent Fundamentals
| Return On Equity | -1.93 | ||||
| Return On Asset | -0.59 | ||||
| Operating Margin | (3.41) % | ||||
| Current Valuation | 12.55 M | ||||
| Shares Outstanding | 8.98 M | ||||
| Shares Owned By Insiders | 1.05 % | ||||
| Shares Owned By Institutions | 7.98 % | ||||
| Number Of Shares Shorted | 537.78 K | ||||
| Price To Book | 4.44 X | ||||
| Price To Sales | 4.35 X | ||||
| Revenue | 3.05 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (9.34 M) | ||||
| Net Income | (10.57 M) | ||||
| Cash And Equivalents | 8.28 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 281.81 K | ||||
| Current Ratio | 2.33 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (9.68 M) | ||||
| Short Ratio | 2.12 X | ||||
| Earnings Per Share | (2.00) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 53 | ||||
| Beta | 4.59 | ||||
| Market Capitalization | 13.29 M | ||||
| Total Asset | 8.25 M | ||||
| Retained Earnings | (62.53 M) | ||||
| Working Capital | (1.21 M) | ||||
| Net Asset | 8.25 M |
About Intelligent Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.